Table 1
OC-007 Results of the interim per protocol (PP) analysis
Active group (PP)
Placebo group (PP)
p-Value (PP)
AAD
0
4 (11.4%)
p = 0.11
CDAD
0
0
p = 1.0
LOS (days)
8
10.2
p = 0.31
30-day mortality
0
0
p = 1.0